OEM Natural Formulation Manufacturers & Supplier

A botanical CRO/CDMO provides full-cycle R&D and contract manufacturing for plant-derived products. Unlike standard chemical CDMOs, we specialize in overcoming complex botanical natural variability: high-throughput active ingredient screening, multi-origin potency evaluation, HPTLC/HPLC fingerprint method development, extraction process optimization, toxicity and cell bioassays, animal disease models, human clinical trials (Phase I–IV), and GMP batch production of bulk actives and packaged finished products.

Yes. MedGence operates integrated laboratory suites, pilot-scale facilities, and commercial GMP workshops under unified technical leadership. This eliminates technical transfer friction, yield degradation, and assay misalignment that routinely happen when research and manufacturing are fragmented across multiple contractors.

We deploy High-Performance Thin-Layer Chromatography (HPTLC) for qualitative botanical identity, High-Performance Liquid Chromatography (HPLC) coupled with DAD/MS detectors for marker quantification, Gas Chromatography (GC) for volatile components and residual solvents, and chromatographic fingerprinting to verify batch conformity and detect synthetic spiking or inferior species adulteration.

We operate exclusively under legally binding bi-lateral Non-Disclosure Agreements (NDAs). All client recipes, customized isolation techniques, and batch documentation remain strictly private property. Manufacturing is partitioned in segregated clean-room suites with restricted access protocols, guaranteeing zero exposure of your competitive advantage.

Bulk active ingredients are supplied as concentrated aqueous/ethanolic liquids, spray-dried micro-fine powders, vacuum pastes, and cold-pressed or steam-distilled volatile oils. Finished consumer products include hard-gelatin and vegan capsules, liquid softgels, coated tablets, effervescent powders, oral liquids/drops, and dispersible granules packaged in blister packs, bottles, or single-serve stick packs.

Yes. We structure both exploratory small-cohort human efficacy trials for dietary supplements and fully compliant GCP Phase I, II, III, and IV clinical studies designed to satisfy regulatory authorities for Botanical New Drug Applications (NDAs) and functional claims.